237 results
SC14D9C
EX-99.5
BLUE
bluebird bio, Inc.
21 Feb 25
Written communication relating to third party tender offer
4:48pm
chapter is expected to bring financial stability and additional investments to expand access and improve the gene therapy experience for patients … to patient access and partnering with the [CALD/beta-thalassemia/sickle cell disease community] remains as strong as ever and all activities related
SC14D9C
EX-99.6
BLUE
bluebird bio, Inc.
21 Feb 25
Written communication relating to third party tender offer
4:48pm
this agreement marks a new chapter for the company, I wanted to reach out personally to let you know that our commitment to patient access and to our … partnership with [company name] remains unchanged. We do not anticipate any immediate changes to our day-to-day processes related to patient access
SC14D9C
EX-99.3
BLUE
bluebird bio, Inc.
21 Feb 25
Written communication relating to third party tender offer
4:48pm
to expand access and improve the gene therapy treatment experience for both patients and providers.
It is expected that the company will have new
SC14D9C
EX-99.2
BLUE
bluebird bio, Inc.
21 Feb 25
Written communication relating to third party tender offer
4:48pm
investment organizations.
This is a significant and positive step forward that will enable bluebird to maintain operations, secure long-term access
8-K
EX-99.1
BLUE
bluebird bio, Inc.
21 Feb 25
Entry into a Material Definitive Agreement
8:21am
and expand patient access to bluebird’s life-changing gene therapies.”
“Carlyle’s healthcare and Abingworth teams have significant experience investing … years. Today, we are proving and scaling the commercial model for gene therapy and delivering innovative solutions for access to patients, providers
8-K
EX-10.1
xpqyklosar28pa5
21 Feb 25
Entry into a Material Definitive Agreement
8:21am
8-K
EX-2.1
p3h47wbx8 6qng2
21 Feb 25
Entry into a Material Definitive Agreement
8:21am
8-K
EX-99.1
7vq4o23vwoecy3d
14 Nov 24
Results of Operations and Financial Condition
7:01am
DEFA14A
g7df76b ivsaob
6 Nov 24
Additional proxy soliciting materials
4:25pm
DEFA14A
77l6yxb24l
15 Oct 24
Additional proxy soliciting materials
8:00am
8-K
EX-99.1
h1keepw7mygz4o
24 Sep 24
Cost Associated with Exit or Disposal Activities
7:03am